Literature DB >> 28723704

Trends and territorial inequalities of incidence and survival of childhood leukaemia and their relations to socioeconomic status in Hungary, 1971-2015.

Zsuzsanna Jakab1, Attila Juhasz, Csilla Nagy, Dezso Schuler, Miklos Garami.   

Abstract

The Hungarian Childhood Cancer Registry, a population-based national registry of the Hungarian Paediatric Haemato-Oncology Network founded in 1971, monitors the incidence and mortality of childhood cancer. Our aims were to carry out a longitudinal study to investigate the trends and spatial inequalities of incidence and survival of leukaemia, and the association between survival and deprivation in Hungary. All cases of childhood leukaemia and myelodysplasia were analysed (3157 cases, 1971-2015, age: 0-14 years). Time trends and the annual percentage change in direct standardized incidence and mortality were assessed. Survival and association with deprivation were assessed using the Kaplan-Meier method and Cox regression. Incidence rates of leukaemia (23.5-56.0/million) increased with an average annual percent change (AAPC) of 1%, determined by an increase in the incidence of acute lymphoblastic leukaemia (14.6-39.2/million, AAPC: 1.25%). Kaplan-Meier analysis showed a significant improvement in overall survival over the study period. Starting from 25% of cases surviving 5 years in the 70s; the overall 5-year survival reached 80% by 2010. Survival differences were observed with sex, leukaemia type and age at diagnosis. A reverse association was found in the survival probability of leukaemia by degree of deprivation. The Cox proportional hazards model verified a significant reverse association with deprivation [hazard ratio=1.08 (1.04-1.12)]. This is the first nationwide study to confirm the prognostic role of deprivation on the basis of a large cohort of patients with childhood leukaemia during a 45-year period. To maintain further improvement in treatment results, it is important to detect inequalities. Our results showed that deprivation may also be important in the survival of leukaemia.

Entities:  

Mesh:

Year:  2017        PMID: 28723704     DOI: 10.1097/CEJ.0000000000000386

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  9 in total

Review 1.  Spatial and temporal variations of childhood cancers: Literature review and contribution of the French national registry.

Authors:  Stéphanie Goujon; Evangelia Kyrimi; Laure Faure; Sandra Guissou; Denis Hémon; Brigitte Lacour; Jacqueline Clavel
Journal:  Cancer Med       Date:  2018-09-19       Impact factor: 4.452

2.  Workforce crisis in primary healthcare worldwide: Hungarian example in a longitudinal follow-up study.

Authors:  Magor Papp; László Kőrösi; János Sándor; Csilla Nagy; Attila Juhász; Róza Ádány
Journal:  BMJ Open       Date:  2019-07-23       Impact factor: 2.692

3.  Leukemia mortality in children from Latin America: trends and predictions to 2030.

Authors:  J Smith Torres-Roman; Bryan Valcarcel; Pedro Guerra-Canchari; Camila Alves Dos Santos; Isabelle Ribeiro Barbosa; Carlo La Vecchia; Katherine A McGlynn; Dyego Leandro Bezerra de Souza
Journal:  BMC Pediatr       Date:  2020-11-07       Impact factor: 2.125

4.  Preventive Metformin Monotherapy Medication Prescription, Redemption and Socioeconomic Status in Hungary in 2018-2019: A Cross-Sectional Study.

Authors:  Csilla Nagy; Attila Juhász; Péter Pikó; Judit Diószegi; György Paragh; Zoltán Szabó; Orsolya Varga; Róza Ádány
Journal:  Int J Environ Res Public Health       Date:  2021-02-24       Impact factor: 3.390

5.  Survival in Children Below the Age of 15 Years With Leukemia: Temporal Patterns in Eastern and Western Germany Since German Reunification.

Authors:  Maike Wellbrock; Hajo Zeeb; Claudia Spix; Desiree Grabow; Arndt Borkhardt; Friederike Erdmann
Journal:  Hemasphere       Date:  2022-07-15

6.  Persistently high incidence rates of childhood acute leukemias from 2010 to 2017 in Mexico City: A population study from the MIGICCL.

Authors:  Janet Flores-Lujano; David Aldebarán Duarte-Rodríguez; Elva Jiménez-Hernández; Jorge Alfonso Martín-Trejo; Aldo Allende-López; José Gabriel Peñaloza-González; María Luisa Pérez-Saldivar; Aurora Medina-Sanson; José Refugio Torres-Nava; Karina Anastacia Solís-Labastida; Luz Victoria Flores-Villegas; Rosa Martha Espinosa-Elizondo; Raquel Amador-Sánchez; Martha Margarita Velázquez-Aviña; Laura Elizabeth Merino-Pasaye; Nora Nancy Núñez-Villegas; Ana Itamar González-Ávila; María de Los Ángeles Del Campo-Martínez; Martha Alvarado-Ibarra; Vilma Carolina Bekker-Méndez; Rocío Cárdenas-Cardos; Silvia Jiménez-Morales; Roberto Rivera-Luna; Haydee Rosas-Vargas; Norma C López-Santiago; Angélica Rangel-López; Alfredo Hidalgo-Miranda; Elizabeth Vega; Minerva Mata-Rocha; Omar Alejandro Sepúlveda-Robles; José Arellano-Galindo; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré
Journal:  Front Public Health       Date:  2022-09-14

7.  Healthcare Utilization and All-Cause Premature Mortality in Hungarian Segregated Roma Settlements: Evaluation of Specific Indicators in a Cross-Sectional Study.

Authors:  János Sándor; Anita Pálinkás; Ferenc Vincze; Nóra Kovács; Valéria Sipos; László Kőrösi; Zsófia Falusi; László Pál; Gergely Fürjes; Magor Papp; Róza Ádány
Journal:  Int J Environ Res Public Health       Date:  2018-08-24       Impact factor: 3.390

8.  Antithrombotic Preventive Medication Prescription Redemption and Socioeconomic Status in Hungary in 2016: A Cross-Sectional Study.

Authors:  Attila Juhász; Csilla Nagy; Orsolya Varga; Klára Boruzs; Mária Csernoch; Zoltán Szabó; Róza Ádány
Journal:  Int J Environ Res Public Health       Date:  2020-09-19       Impact factor: 3.390

9.  Characteristics of the Third COVID-19 Pandemic Wave with Special Focus on Socioeconomic Inequalities in Morbidity, Mortality and the Uptake of COVID-19 Vaccination in Hungary.

Authors:  Beatrix Oroszi; Attila Juhász; Csilla Nagy; Judit Krisztina Horváth; Krisztina Eszter Komlós; Gergő Túri; Martin McKee; Róza Ádány
Journal:  J Pers Med       Date:  2022-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.